We want medicine to be more accessible, available, and affordable.
Our #EUPharmaStrategy legislative reform proposes a single market of medicines that:
🔸 is patient-centric
🔹 fosters innovation
🔸 fights antimicrobial resistance
🔹 is environmentally friendly ↓
🐦🔗: https://n.respublicae.eu/EU_Commission/status/1651180648810381312
Patients across the EU deserve timely access to high quality, affordable medicines.
We are proposing a modern regulatory framework & industry incentives to make unmet medical needs and shortages of critical medicines a thing of the past.
🐦🔗: https://n.respublicae.eu/EU_Commission/status/1651187083552104448
We want to ensure that the EU pharmaceutical industry delivers for patients and is globally competitive by:
🔹 Promoting innovation
🔸 Ensuring faster authorisation of new medicines
🔹 Incentivising R&D in unmet medical needs
🐦🔗: https://n.respublicae.eu/EU_Commission/status/1651187087524102145
Antimicrobial resistance causes 35,000 deaths per year in the EU.
AMR occurs when antimicrobials stop being effective due to overuse & misuse.
We have to ensure that antimicrobials are innovative, more widely available & used prudently.
#HealthUnion
→ http://europa.eu/!pTrgGx
🐦🔗: https://n.respublicae.eu/EU_Commission/status/1651187085389250560